Molecular alterations of IL-6R, lck and c-myc genes in transforming monoclonal gammopathies of undetermined significance

被引:11
作者
Gernone, A [1 ]
Dammacco, F [1 ]
机构
[1] UNIV BARI, DEPT BIOMED SCI & HUMAN ONCOL, SECT INTERNAL MED & CLIN ONCOL, SCH MED, BARI, ITALY
关键词
molecular alterations; myeloma; MGUS; IL-6R; oncogenes;
D O I
10.1046/j.1365-2141.1996.d01-1685.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We studied the molecular alterations of IL-6R, lck and c-myc genes in the tumour cells of 50 patients with multiple myeloma (MM) and 20 patients with monoclonal gammopathies of undetermined significance (MGUS). Southern blot analysis revealed a 5.3 kb IL-6R amplified band by digestion with EcoRI and HindIII in three MGUS patients, but no IL-6R gene alteration was found in MM patients. BamHI digestion revealed a 6.2 kb rearranged band of the lck gene in two MGUS patients with IL-6R amplification, In one MGUS patient we detected a rearrangement upstream of the lck coding region. Myc rearrangement was observed in three MM and two MGUS patients who showed coexistent lck rearrangement and IL-6R amplification, These molecular alterations were detected in the MGUS patients with an IgA monoclonal component, who showed a rapid progression into aggressive MM. Myc rearrangement seems to be associated with a small group of a clinically aggressive MM at diagnosis, secreting IgA or k light chains. Multiple rearrangements and/or molecular alterations are likely to occur at the time of MGUS-IgA transformation into aggressive MM and myc rearrangement may promote a positive pressure for transformation and progression, MM tumourigenesis remains a heterogenous multistep process involving the deregulation of many genes and gene products.
引用
收藏
页码:623 / 631
页数:9
相关论文
共 34 条
[1]   DNA REARRANGEMENT AND CONSTITUTIVE EXPRESSION OF THE INTERLEUKIN 6-GENE IN A MOUSE PLASMACYTOMA [J].
BLANKENSTEIN, T ;
QIN, ZH ;
LI, WQ ;
DIAMANTSTEIN, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (03) :965-970
[2]   A FUNCTION FOR THE LCK PROTO-ONCOGENE [J].
BOLEN, JB ;
VEILLETTE, A .
TRENDS IN BIOCHEMICAL SCIENCES, 1989, 14 (10) :404-407
[3]  
CHEUNG RK, 1991, J BIOL CHEM, V266, P8667
[4]  
CROCE CM, 1985, BLOOD, V65, P1
[5]   TRANSLOCATION AND REARRANGEMENTS OF THE C-MYC ONCOGENE LOCUS IN HUMAN UNDIFFERENTIATED B-CELL LYMPHOMAS [J].
DALLAFAVERA, R ;
MARTINOTTI, S ;
GALLO, RC ;
ERIKSON, J ;
CROCE, CM .
SCIENCE, 1983, 219 (4587) :963-967
[6]  
DURIE BGM, 1977, RECENT ADV HAEMATOLO, P243
[7]  
FATTORI E, 1994, BLOOD, V83, P2570
[8]   EVOLUTION OF B-CELL MALIGNANCY - PRE-B-CELL LEUKEMIA RESULTING FROM MYC ACTIVATION IN A B-CELL NEOPLASM WITH A REARRANGED BCL2 GENE [J].
GAUWERKY, CE ;
HALUSKA, FG ;
TSUJIMOTO, Y ;
NOWELL, PC ;
CROCE, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (22) :8548-8552
[9]   STIMULATION OF PROTEIN TYROSINE PHOSPHORYLATION BY THE LYMPHOCYTE-B ANTIGEN RECEPTOR [J].
GOLD, MR ;
LAW, DA ;
DEFRANCO, AL .
NATURE, 1990, 345 (6278) :810-813
[10]   PURIFICATION TO HOMOGENEITY AND CHARACTERIZATION OF HUMAN B-CELL DIFFERENTIATION FACTOR (BCDF OR BSFP-2) [J].
HIRANO, T ;
TAGA, T ;
NAKANO, N ;
YASUKAWA, K ;
KASHIWAMURA, S ;
SHIMIZU, K ;
NAKAJIMA, K ;
PYUN, KH ;
KISHIMOTO, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (16) :5490-5494